4.3 Article

Therapeutic outcome of diphencyprone and its correlation with serum cytokine profile in alopecia areata

Related references

Note: Only part of the references are listed.
Article Dermatology

The profile of cytokines (IL-2, IFN-γ, IL-4, IL-10, IL-17A, and IL-23) in active alopecia areata

Ram Kishan Gautam et al.

JOURNAL OF COSMETIC DERMATOLOGY (2020)

Article Allergy

Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17/TH22 skewing

Mayte Suarez-Farinas et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)

Article

Clinical Efficacy of Diphenylcyclopropenone in Alopecia Areata: Retrospective Data Analysis of 50 Patients

Katherine S. Chiang et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS (2015)

Letter Dermatology

Chinese experience in the treatment of alopecia areata with diphenylcyclopropenone

Rujing Pan et al.

JOURNAL OF DERMATOLOGY (2015)

Letter Dermatology

Lifetime Incidence Risk of Alopecia Areata Estimated at 2.1% by Rochester Epidemiology Project, 1990-2009

Sultan A. Mirzoyev et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)

Review Dermatology

Alopecia areata: An update

Kolalapudi Anjaneyulu Seetharam

INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY (2013)

Review Dermatology

Cytokine pathways and interactions in alopecia areata

Cerrene N. Giordano et al.

EUROPEAN JOURNAL OF DERMATOLOGY (2013)

Letter Dermatology

The Safety and Efficacy of Diphencyprone for the Treatment of Alopecia Areata in Children

Jennifer M. Salsberg et al.

ARCHIVES OF DERMATOLOGY (2012)

Article Dermatology

Topical immunotherapy with diphenylcyclopropenone in the treatment of chronic extensive alopecia areata

D. Sotiriadis et al.

CLINICAL AND EXPERIMENTAL DERMATOLOGY (2007)

Article Dermatology

The use of topical diphenylcyclopropenone for the treatment of extensive alopecia areata

C Cotellessa et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2001)